Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-26

Clinical Trial Update: Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab

View source ↗

Summary

A completed Greek clinical trial evaluated how adalimumab affects work productivity and sleep in patients with rheumatic diseases treated with the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Rheumatoid Arthritis, Ankylosing Spondylitis | Status: COMPLETED | Results posted: 2015-08-26